American Capital Management, Inc.
+6.82%
3M Return
$8.800
-0.215 (-2.44%)Zum Schluss
Cognyte Software Ltd is an Israel-based company. The main activity is focused on providing security and analytics software. The Company designs software that empowers governments and enterprises with Actionable Intelligence for solutions accelerate security investigations to successfully identify, neutralize, and prevent threats.
Cognyte Software Ltd appears to be a good buy right now due to its recent contract wins and improving revenue trends. The current price is $8.80, which is significantly below the analyst price target of $13, suggesting a potential upside of approximately 47%. Additionally, the gross margin has improved to 74.03%, indicating better profitability. However, the main risk is the negative earnings per share (EPS) of -0.04 reported last quarter, which reflects ongoing profitability challenges.
Lake Street
$13
2026-03-02
Lake Street
2026-03-02
Kursziel
$13
Needham
—
2025-04-08
Needham
2025-04-08
Kursziel
—
Needham
—
2025-04-02
Needham
2025-04-02
Kursziel
—
Needham
—
2024-12-12
Needham
2024-12-12
Kursziel
—
Needham
—
2024-09-10
Needham
2024-09-10
Kursziel
—

Cognyte to Showcase Innovations at IAFCI Conference 2026

Cognyte Secures $5M Deal with NATO Security Agency

Cognyte Secures $5M Contract with National Security Agency

Cognyte Software Reports Strong Q1 Growth with Double-Digit Revenue Increase

Cognyte Beats Q1 Sales Expectations but Misses Earnings
Cognyte Software Ltd is an Israel-based company. The main activity is focused on providing security and analytics software. The Company designs software that empowers governments and enterprises with Actionable Intelligence for solutions accelerate security investigations to successfully identify, neutralize, and prevent threats. It operates in the Technology sector (PREPACKAGED SOFTWARE industry).
Cognyte Software Ltd appears to be a good buy right now due to its recent contract wins and improving revenue trends. The current price is $8.80, which is significantly below the analyst price target of $13, suggesting a potential upside of approximately 47%. Additionally, the gross margin has improved to 74.03%, indicating better profitability. However, the main risk is the negative earnings per share (EPS) of -0.04 reported last quarter, which reflects ongoing profitability challenges.
2 analysts cover CGNT: 2 rate it Buy, 0 Hold and 0 Sell.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.